Commission Decision of 9 August 2011 on appointing members of the Committee for Orphan Medicinal Products (Text with EEA relevance) 2011/C 234/06
Grade B
mapped from publisher markup. A grade says how a document's structure was obtained, not how reliable the law is.
Address https://gelex.eu/eli/EU/decision/oj/C/2011/234/06@2011-08-09/en
Contents
THE EUROPEAN COMMISSION,
Having regard to the Treaty on the Functioning of the European Union,
Having regard to Regulation (EC) No 141/2000 of the European Parliament and of the Council of 16 December 1999 on orphan medicinal products, and in particular Article 4(3) thereof,
Having regard to the recommendation of the European Medicines Agency of 25 May 2011,
Whereas:
(1) The term of office of two members of the Committee for Orphan Medicinal Products which were appointed by the Commission on the recommendation from the European Medicines Agency expired in July 2011.
(2) The European Medicines Agency has recommended the reappointment of these persons.
(3) The members of the Committee shall be appointed for a period of three years starting on 1 September 2011,
HAS DECIDED AS FOLLOWS:
Sole Article
On the recommendation of the European Medicines Agency, the following are hereby reappointed members of the Committee for Orphan Medicinal Products for a term of three years from 1 September 2011:
Prof. János BORVENDÉG
Prof. Bruno SEPODES
Done at Brussels, 9 August 2011. For the Commission John Dalli Member of the Commission